Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Accumulated Depreciation & Amortization (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $3.1 million as the latest value for Q4 2019.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 5.85% to $3.1 million in Q4 2019 year-over-year; TTM through Dec 2019 was $3.1 million, a 5.85% decrease, with the full-year FY2019 number at $3.1 million, down 5.85% from a year prior.
  • Accumulated Depreciation & Amortization was $3.1 million for Q4 2019 at Forte Biosciences, down from $3.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.3 million in Q4 2018 to a low of $2.4 million in Q4 2016.
  • A 4-year average of $2.9 million and a median of $2.9 million in 2017 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: rose 23.1% in 2018, then fell 5.85% in 2019.
  • Forte Biosciences' Accumulated Depreciation & Amortization stood at $2.4 million in 2016, then rose by 12.1% to $2.7 million in 2017, then grew by 23.1% to $3.3 million in 2018, then dropped by 5.85% to $3.1 million in 2019.
  • Per Business Quant, the three most recent readings for FBRX's Accumulated Depreciation & Amortization are $3.1 million (Q4 2019), $3.3 million (Q4 2018), and $2.7 million (Q4 2017).